Back to Agenda
A New Path Forward for Using Decentralized Clinical Trials
Session Chair(s)
Penny Randall, MD
Vice President and Head, CNS Center of Excellence, IQVIA, United States
Barriers are hindering the widespread use of decentralized clinical trials. However, new recommendations developed by CTTI offer new approaches to improve recruitment and retention, participant diversity, and the research experience for patients.
Learning Objective : Describe proven methods for executing decentralized clinical trials through telemedicine and mobile healthcare providers; Discuss actionable recommendations for navigating state medical licensing laws and issues with drug supply chain of custody; Identify the broad continuum of hybrid protocol designs possibilities for implementing decentralized clinical trials.
Speaker(s)
Laura Byrnes Podolsky, JD, MPH
General Counsel, Science 37, United States
Panelist
Gail Adinamis
CEO, GlobalCare Clinical Trials, LLC, United States
Panelist
Michael O'Brien, CPA
Life Sciences Consultant, MJO Consulting, LLC, United States
Panelist
Have an account?